The Allstate Co. (NYSE:ALL) Shares Purchased by Thurston Springer Miller Herd & Titak Inc.

Thurston Springer Miller Herd & Titak Inc. increased its holdings in The Allstate Co. (NYSE:ALLFree Report) by 72.7% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,981 shares of the insurance provider’s stock after acquiring an additional 834 shares during the period. Thurston Springer Miller Herd & Titak Inc.’s holdings in Allstate were worth $382,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ALL. Dimensional Fund Advisors LP increased its position in shares of Allstate by 3.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock worth $229,545,000 after purchasing an additional 47,038 shares during the last quarter. Citizens Financial Group Inc. RI increased its position in shares of Allstate by 38.1% during the second quarter. Citizens Financial Group Inc. RI now owns 2,312 shares of the insurance provider’s stock valued at $371,000 after acquiring an additional 638 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Allstate in the 2nd quarter valued at approximately $32,411,000. Axxcess Wealth Management LLC lifted its holdings in shares of Allstate by 117.7% in the 2nd quarter. Axxcess Wealth Management LLC now owns 4,357 shares of the insurance provider’s stock worth $696,000 after acquiring an additional 2,356 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. boosted its position in shares of Allstate by 8.9% during the 2nd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 4,137 shares of the insurance provider’s stock worth $661,000 after purchasing an additional 337 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Price Performance

Allstate stock opened at $188.01 on Thursday. The stock has a market cap of $49.79 billion, a P/E ratio of 12.18, a price-to-earnings-growth ratio of 1.70 and a beta of 0.52. The company has a fifty day simple moving average of $195.89 and a 200-day simple moving average of $186.07. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 12-month low of $150.17 and a 12-month high of $209.88.

Allstate (NYSE:ALLGet Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same period in the previous year, the business earned $0.81 EPS. Allstate’s revenue for the quarter was up 14.7% on a year-over-year basis. Equities analysts expect that The Allstate Co. will post 16.26 EPS for the current fiscal year.

Allstate Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were paid a $0.92 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.96%. Allstate’s dividend payout ratio is currently 23.83%.

Analysts Set New Price Targets

ALL has been the topic of a number of research analyst reports. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a research report on Wednesday, January 8th. Keefe, Bruyette & Woods increased their target price on Allstate from $235.00 to $243.00 and gave the stock an “outperform” rating in a research note on Friday, January 10th. JPMorgan Chase & Co. lifted their target price on Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Bank of America increased their price target on shares of Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Wells Fargo & Company lifted their price objective on shares of Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $218.13.

View Our Latest Stock Report on ALL

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Read More

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.